Humira pricing varies depending on factors such as insurance coverage, pharmacy, and the specific formulation.
How Much Does Humira Cost?
Without insurance, a one-month supply of Humira can cost approximately $6,900 to $7,000. For a year's supply, the cost can range from $80,000 to $84,000. However, these are list prices, and actual out-of-pocket costs for patients can be significantly lower due to insurance plans and patient assistance programs [1].
What Influences Humira's Price?
The price of Humira is influenced by its status as a biologic drug, which involves complex and expensive manufacturing processes. Additionally, the drug's effectiveness in treating multiple autoimmune conditions contributes to its pricing. Patent protection also plays a role, allowing the manufacturer to set prices without direct competition for a period [2].
How Can I Reduce the Cost of Humira?
Several options can help reduce the cost of Humira. These include:
* Insurance Coverage: Most insurance plans cover Humira, but copayments and deductibles will vary. Patients should check their specific plan details.
* Manufacturer Assistance Programs: AbbVie, the manufacturer of Humira, offers patient assistance programs like the Humira Complete Savings Card, which can reduce out-of-pocket costs for eligible patients with commercial insurance to as low as $5 per month [3].
* Discount Cards and Coupons: Online pharmacies and discount card providers may offer coupons or savings programs that can lower the cost of the drug [1].
* Biosimilars: As patents expire, biosimilar versions of Humira are becoming available, which are expected to offer lower-cost alternatives.
When Will Humira Patents Expire and Biosimilars Become Available?
The patent landscape for Humira is complex, with numerous patents covering its formulation, manufacturing, and uses. Several biosimilar versions of Humira have received FDA approval. In the U.S., AbbVie reached agreements that allow for the launch of certain biosimilars starting in 2023 [4].
How Do Humira Biosimilars Compare in Price?
Biosimilar versions of Humira are anticipated to be significantly less expensive than the originator drug. While exact pricing will vary by manufacturer and market, they are expected to offer substantial savings, similar to how biosimilars for other biologic drugs have reduced treatment costs [4].
Where Can I Find Humira Savings and Information?
Resources for Humira savings and information include the official Humira website, which details patient assistance programs, and DrugPatentWatch.com, which tracks patent expirations and the emergence of biosimilars for a wide range of drugs [1, 4]. Patients can also consult with their healthcare provider or pharmacist to explore available cost-saving options.